KBC Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.3M | Sell |
102,199
-1,139
| -1% | -$199K | 0.05% | 272 |
|
|
2025
Q4 | $17.6M | Buy |
103,338
+7,055
| +7% | +$1.08M | 0.04% | 281 |
|
|
2025
Q3 | $12.7M | Sell |
96,283
-150,029
| -61% | -$18M | 0.03% | 320 |
|
|
2025
Q2 | $26.1M | Buy |
246,312
+2,374
| +1% | +$258K | 0.07% | 240 |
|
|
2025
Q1 | $30.3M | Buy |
243,938
+7,620
| +3% | +$994K | 0.09% | 214 |
|
|
2024
Q4 | $29.1M | Buy |
236,318
+8,014
| +4% | +$945K | 0.08% | 232 |
|
|
2024
Q3 | $25.4M | Sell |
228,304
-149,549
| -40% | -$16.4M | 0.08% | 231 |
|
|
2024
Q2 | $40.3M | Buy |
377,853
+79,797
| +27% | +$8.77M | 0.12% | 154 |
|
|
2024
Q1 | $35.9M | Buy |
298,056
+134,198
| +82% | +$16.4M | 0.11% | 176 |
|
|
2023
Q4 | $20.2M | Buy |
163,858
+153,386
| +1,465% | +$19.1M | 0.07% | 250 |
|
|
2023
Q3 | $1.35M | Buy |
10,472
+3,321
| +46% | +$443K | 0.01% | 649 |
|
|
2023
Q2 | $887K | Sell |
7,151
-24,849
| -78% | -$3.34M | ﹤0.01% | 707 |
|
|
2023
Q1 | $4.68M | Sell |
32,000
-54,995
| -63% | -$8.13M | 0.02% | 493 |
|
|
2022
Q4 | $13.9M | Sell |
86,995
-23,547
| -21% | -$3.45M | 0.07% | 255 |
|
|
2022
Q3 | $14.7M | Sell |
110,542
-12,300
| -10% | -$1.87M | 0.08% | 251 |
|
|
2022
Q2 | $19.2M | Buy |
122,842
+54,861
| +81% | +$8.45M | 0.1% | 228 |
|
|
2022
Q1 | $10.6M | Buy |
67,981
+54,408
| +401% | +$7.9M | 0.04% | 321 |
|
|
2021
Q4 | $1.73M | Sell |
13,573
-118
| -0.9% | -$15.5K | 0.01% | 627 |
|
|
2021
Q3 | $1.78M | Sell |
13,691
-268,653
| -95% | -$40.6M | 0.01% | 677 |
|
|
2021
Q2 | $50.2M | Buy |
282,344
+209,110
| +286% | +$36.2M | 0.09% | 229 |
|
|
2021
Q1 | $12M | Buy |
73,234
+6,988
| +11% | +$1.15M | 0.02% | 441 |
|
|
2020
Q4 | $60.1M | Buy |
66,246
+45,744
| +223% | +$6.81M | 0.03% | 449 |
|
|
2020
Q3 | $2.92M | Sell |
20,502
-4,758
| -19% | -$590K | 0.01% | 647 |
|
|
2020
Q2 | $2.79M | Sell |
25,260
-28,133
| -53% | -$3.11M | 0.01% | 626 |
|
|
2020
Q1 | $5.33M | Sell |
53,393
-90,940
| -63% | -$11.8M | 0.04% | 364 |
|
|
2019
Q4 | $21.5M | Buy |
144,333
+35,227
| +32% | +$4.79M | 0.14% | 188 |
|
|
2019
Q3 | $14M | Buy |
109,106
+4,943
| +5% | +$663K | 0.1% | 244 |
|
|
2019
Q2 | $14.8M | Buy |
104,163
+962
| +0.9% | +$129K | 0.11% | 215 |
|
|
2019
Q1 | $14.8M | Sell |
103,201
-59,242
| -36% | -$7.73M | 0.12% | 210 |
|
|
2018
Q4 | $20.1M | Buy |
162,443
+27,107
| +20% | +$4.02M | 0.22% | 115 |
|
|
2018
Q3 | $22.8M | Buy |
135,336
+25,471
| +23% | +$4.38M | 0.17% | 154 |
|
|
2018
Q2 | $18.9M | Sell |
109,865
-19,762
| -15% | -$3.23M | 0.16% | 169 |
|
|
2018
Q1 | $19.6M | Sell |
129,627
-51,589
| -28% | -$7.57M | 0.18% | 149 |
|
|
2017
Q4 | $24.4M | Sell |
181,216
-72,317
| -29% | -$10M | 0.21% | 124 |
|
|
2017
Q3 | $37.1M | Sell |
253,533
-26,579
| -9% | -$4.02M | 0.34% | 67 |
|
|
2017
Q2 | $43.6M | Sell |
280,112
-32,549
| -10% | -$4.98M | 0.42% | 51 |
|
|
2017
Q1 | $45.4M | Buy |
312,661
+184,046
| +143% | +$24M | 0.41% | 55 |
|
|
2016
Q4 | $14M | Sell |
128,615
-42,993
| -25% | -$4.79M | 0.14% | 182 |
|
|
2016
Q3 | $20.8M | Buy |
171,608
+50,210
| +41% | +$6.77M | 0.25% | 95 |
|
|
2016
Q2 | $17.2M | Sell |
121,398
-3,367
| -3% | -$496K | 0.25% | 96 |
|
|
2016
Q1 | $16.3M | Buy |
124,765
+25,469
| +26% | +$3.17M | 0.27% | 86 |
|
|
2015
Q4 | $14M | Buy |
99,296
+8,353
| +9% | +$1.16M | 0.26% | 102 |
|
|
2015
Q3 | $12.1M | Sell |
90,943
-23,746
| -21% | -$4.09M | 0.24% | 108 |
|
|
2015
Q2 | $20.2M | Sell |
114,689
-10,073
| -8% | -$1.81M | 0.26% | 102 |
|
|
2015
Q1 | $21.6M | Buy |
124,762
+66,623
| +115% | +$11.4M | 0.28% | 97 |
|
|
2014
Q4 | $9.52M | Buy |
58,139
+47,187
| +431% | +$7.83M | 0.11% | 216 |
|
|
2014
Q3 | $1.76M | Sell |
10,952
-49,782
| -82% | -$7.65M | 0.06% | 366 |
|
|
2014
Q2 | $8.93M | Buy |
60,734
+50,437
| +490% | +$6.99M | 0.1% | 246 |
|
|
2014
Q1 | $1.43M | Sell |
10,297
-11,261
| -52% | -$1.7M | 0.02% | 571 |
|
|
2013
Q4 | $2.73M | Buy |
21,558
+8,505
| +65% | +$880K | 0.04% | 438 |
|
|
2013
Q3 | $1.2M | Buy |
+13,053
| New | +$1.05M | 0.02% | 640 |
|
Other funds holding JAZZ
VPM
VCM
EC
KBC Group's JAZZ Position: Q1 2026 in Review
KBC Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.1% in Q1 2026, selling an estimated $199K and leaving 102,199 shares worth $19.3M. The position accounts for 0.05% of the portfolio, ranked #272.
KBC Group first reported a position in JAZZ in Q3 2013 and has held it in 51 quarters since. The position peaked at $60.1M in Q4 2020. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- KBC Group held 102,199 shares of Jazz Pharmaceuticals worth $19.3M as of Q1 2026.
- KBC Group sold 1,139 Jazz Pharmaceuticals shares in Q1 2026, an estimated $199K.
- Jazz Pharmaceuticals made up 0.05% of KBC Group's portfolio in Q1 2026, its #272 holding.
- KBC Group first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
- KBC Group's Jazz Pharmaceuticals position peaked at $60.1M in Q4 2020.
- 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.